Regulatory30 May 2026, 01:31 pm
Dr. Reddy's Files 20-F Report for FY26 with US SEC
AI Summary
Dr. Reddy's Laboratories Ltd has filed its Annual Report in Form 20-F for the fiscal year ended March 31, 2026, with the United States Securities and Exchange Commission on May 30, 2026. The report, containing annual consolidated financial statements prepared under International Financial Reporting Standards (IFRS), is available on the company's website.
Key Highlights
- Dr. Reddy's filed its Form 20-F for FY26 with the US SEC.
- The report includes consolidated financial statements under IFRS.
- The filing was made on May 30, 2026.
- The Annual Report is accessible on the company's website.
Price Impact
More from DRREDDY